DIAGNOSTICS AND TREATMENT: New (IR) light on dementias

According to the best estimate, about 5.2 million Americans currently suffer from Alzheimer’s disease. That number is an estimate because physicians have no definitive way to diagnose the condition in living patients. Assured diagnosis occurs only when pathologists identify the microscopic features associated with the disease—amyloid plaques in the brain and tangle-like proteins in nerve cells —after the patients have died. And to date no cure exists for Alzheimer’s or related dementias.

Infrared radiation may offer help in diagnosing Alzheimer’s and possibly reversing the progress of it and other dementias. A group of researchers in the Boston area has developed a spectroscopic technique intended to detect early signs of Alzheimer’s disease. And a British physician has developed an infrared device that has reduced symptoms of dementia in a single patient.

The diagnostic method has already proved capable of identifying amyloid plaques in brain tissue gathered postmortem. Now, the group has started to test the approach in living individuals. “We think the technique has a lot of potential for detecting the disease early on,” says team leader Eugene Hanlon, a research health scientist and program director of the spectroscopy of neurodegenerative disorders in the U.S. Department of Veterans Affairs.

Illuminating brain tissue

In research reported in Optics Letters, Hanlon’s team used near-infrared light to illuminate samples of brain tissue from individuals diagnosed postmortem as suffering from Alzheimer’s disease and from controls without the condition. Team members studied the transmission and reflectance spectra over the wavelength range from 470 to 1000 nm. Why near-IR? “These wavelengths are not strongly absorbed by biological tissues,” Hanlon explains. They can penetrate several centimeters into the tissue. This would allow a technique based on these types of measurements to be used noninvasively in living humans.”

Hanlon’s group, which included researchers from Boston University and Harvard Medical School/Beth Israel Deaconess Medical Center, did not detect spectral lines specific to amyloid plaques and tangles. Rather, it found that the indicators of Alzheimer’s disease affected the overall picture. “The tissue has a very complex spectrum, contributed by numerous components,” Hanlon says. “The presence of the plaques or tangles alters the spectrum as a whole. We evaluate individual spectra and, depending on their properties, relate them to the effects of the pathology—Alzheimer’s disease present or not present.”

What comes next? “We’re trying to see if these basic tissue experiments carried out under laboratory conditions can be carried over into a clinical setting and performed on patients [putatively] diagnosed with Alzheimer’s disease and control patients,” Hanlon says. “Now, you’re going through the skin, the skull, and the cerebrospinal fluid; that’s several extra layers of complexity.” The team will recruit up to 100 patients for the living study. “Within this year I hope to make a definitive report on it,” Hanlon says. However, he notes the problem won’t be solved at that point.

From cold sores to dementias

The other application of infrared radiation to dementia has started on a more ambitious, although smaller scale at British company Virulite. In the late 1990s, James Haslam and Gordon Dougal found that brief daily treatments with IR light around 1072 nm significantly reduced the time needed to heal cold sores produced by the herpes simplex virus. When evidence emerged that the same virus is attached to amyloid plaques in the brain, the pair tested the IR radiation on mice with memory deficits running three-dimensional mazes and found the treatment improved the performances of the mice.

Now Dougal, working with a team at Sunderland University, England, has developed a helmet containing 700 1072 nm LED lights, designed to penetrate the skull of a living human. His subject, was Clem Fennell, a 57-year-old engineer from Cincinnati, OH, who had progressive dementia. After ten days of twice-daily bursts of radiation from the helmet, Fennell began to show marked improvement. “He was monosyllabic when I first saw him, but if I ring now he will answer the phone,” Dougal reported.

Dougal plans a clinical trial with 100 patients. Like the living diagnostic technique, the technology remains to be proved. But both advances provide some hope for patients with Alzheimer’s and other dementias. –PG

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now


Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

SPECTROSCOPY/EPIDEMIOLOGY: FTIR approach quickly, accurately IDs aggressive Staph bacteria

A new infrared (IR) spectroscopy technique operates without the use of complex antibodies to quickly distinguish between strains of Staphylococcus aureus (S. aureus) bacteria, showing which can cau...

NIR spectroscopy instrument assists in monitoring brain injuries

Researchers at the Nałęcz Institute of Biocybernetics and Biomedical Engineering of the Polish Academy of Sciences (IBBE PAS) are developing a near-infrared (NIR) spectroscopy instrument that enabl...

NIR spectroscopy intravascular imaging system receives $25M investment

Medical device maker Infraredx has received a $25 million equity investment from Nipro Corporation, which builds on an exclusive agreement between the two companies for distribution of Infraredx's ...

Raman spectroscopy analyzes lipstick traces non-destructively

Using Raman spectroscopy, it is now possible to identify which brand of lipstick someone was wearing at a crime scene without removing the evidence from its bag, thereby avoiding possible contamina...

(SLIDESHOW) View the July/August 2013 issue

FTIR spectroscopy helps predict bone density, fracture risk

Finnish researchers used bone histomorphometry and Fourier transform infrared (FTIR) spectroscopy to reveal abnormal bone properties in children with vertebral fractures and in children after solid...

FTIR spectroscopy method characterizes Staph bacteria quickly

Scientists at the University of Veterinary Medicine Vienna in Austria have developed an infrared (IR) spectroscopy technique for rapidly distinguishing strains of the bacterium Staphylococcus aureu...

Intravascular imaging system detects cholesterol signature in heart attack patients

Recent work at Spectrum Health has demonstrated the ability of a near-infrared (NIR) spectroscopy intravascular imaging system to detect lipid core plaque in patients with ST-Segment Elevation Myoc...

Ultrafast laser pioneer Alfano garners Prize in Laser Science

The American Physical Society (APS) has awarded the 2013 Arthur L. Schawlow Prize in Laser Science to Distinguished Professor of Science and Engineering Robert Alfano.


LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

Single-molecule tracking promises discoveries, cures

New ways of imaging individual proteins and lipids will ultimately change science and medicine.

Growth in lasers for medicine

At the Lasers and Photonics Marketplace Seminar during SPIE Photonics West 2015, analyst Allen No...

Most Popular Articles



Twitter- BioOptics World

Copyright © 2007-2015. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS